PubMed

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus.

Dörner T, Kaufmann J, Wegener WA, Teoh N, Goldenberg DM, Burmester GR.

Arthritis Res Ther. 2006;8(3):R74. Epub 2006 Apr 21. Erratum in: Arthritis Res Ther. 2008;10(5):406. PMID: 16630358 [PubMed - indexed for MEDLINE]Related articlesFree article

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.

Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O.

Arthritis Res Ther. 2006;8(4):R129.PMID: 16859536 [PubMed - indexed for MEDLINE]Related articlesFree article

A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.

Tanaka Y, Yamamoto K, Takeuchi T, Nishimoto N, Miyasaka N, Sumida T, Shima Y, Takada K, Matsumoto I, Saito K, Koike T.

Mod Rheumatol. 2007;17(3):191-7. Epub 2007 Jun 20.PMID: 17564773 [PubMed - indexed for MEDLINE]Related articles

Novel evidence-based systemic lupus erythematosus responder index.

Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, Chatham WW, Strand V, Weinstein A, Chevrier MR, Zhong ZJ, Freimuth WW.

Arthritis Rheum. 2009 Sep 15;61(9):1143-51.PMID: 19714615 [PubMed - indexed for MEDLINE]Related articles

Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Furman R, Schuster MW, Feldman EJ, Ashe M, Schuster SJ, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Fields SZ, Cesano A, Goldenberg DM.

Clin Cancer Res. 2004 Aug 15;10(16):5327-34.PMID: 15328168 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM.

J Clin Oncol. 2003 Aug 15;21(16):3051-9. Epub 2003 Jul 1.PMID: 12837807 [PubMed - indexed for MEDLINE]Related articles

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.

Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.

Arthritis Rheum. 2009 Apr 15;61(4):482-7.PMID: 19333973 [PubMed - indexed for MEDLINE]Related articles

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.PMID: 17100405 [PubMed - indexed for MEDLINE]Related articles

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

Wallace DJ, Stohl W, Furie RA, Lisse JR, McKay JD, Merrill JT, Petri MA, Ginzler EM, Chatham WW, McCune WJ, Fernandez V, Chevrier MR, Zhong ZJ, Freimuth WW.

Arthritis Rheum. 2009 Sep 15;61(9):1168-78.PMID: 19714604 [PubMed - indexed for MEDLINE]Related articles

B-cell-targeted therapy for systemic lupus erythematosus: an update.

Ding C, Foote S, Jones G.

BioDrugs. 2008;22(4):239-49. Review.PMID: 18611066 [PubMed - indexed for MEDLINE]Related articles

B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.

Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.

Ann Rheum Dis. 2008 Jul;67(7):1011-6. Epub 2007 Oct 25.PMID: 17962238 [PubMed - indexed for MEDLINE]Related articles

Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.

Lindén O, Hindorf C, Cavallin-Ståhl E, Wegener WA, Goldenberg DM, Horne H, Ohlsson T, Stenberg L, Strand SE, Tennvall J.

Clin Cancer Res. 2005 Jul 15;11(14):5215-22.PMID: 16033839 [PubMed - indexed for MEDLINE]Related articlesFree article

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.

Rheumatology (Oxford). 2005 Dec;44(12):1542-5. Epub 2005 Sep 27.PMID: 16188950 [PubMed - indexed for MEDLINE]Related articlesFree article

Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial.

Muller S, Monneaux F, Schall N, Rashkov RK, Oparanov BA, Wiesel P, Geiger JM, Zimmer R.

Arthritis Rheum. 2008 Dec;58(12):3873-83.PMID: 19035498 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.

Strauss SJ, Morschhauser F, Rech J, Repp R, Solal-Celigny P, Zinzani PL, Engert A, Coiffier B, Hoelzer DF, Wegener WA, Teoh NK, Goldenberg DM, Lister TA.

J Clin Oncol. 2006 Aug 20;24(24):3880-6. Epub 2006 Jul 24.PMID: 16864854 [PubMed - indexed for MEDLINE]Related articles

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.

Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, Cai W, Freimuth W; Belimumab Study Group.

Arthritis Res Ther. 2008;10(5):R109. Epub 2008 Sep 11.PMID: 18786258 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

Kalunian KC, Davis JC Jr, Merrill JT, Totoritis MC, Wofsy D; IDEC-131 Lupus Study Group.

Arthritis Rheum. 2002 Dec;46(12):3251-8.PMID: 12483729 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls.

Jacobi AM, Goldenberg DM, Hiepe F, Radbruch A, Burmester GR, Dörner T.

Ann Rheum Dis. 2008 Apr;67(4):450-7. Epub 2007 Aug 2.PMID: 17673490 [PubMed - indexed for MEDLINE]Related articles

Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again.

Eisenberg R.

Arthritis Res Ther. 2006;8(3):108. Epub 2006 May 15.PMID: 16732895 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.

Ho A, Magder LS, Barr SG, Petri M.

Arthritis Rheum. 2001 Oct;44(10):2342-9.PMID: 11665975 [PubMed - indexed for MEDLINE]Related articles